Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, has multifactorial aetiology with complex interactions between genetic and environmental factors. Over 150 ...

Purpose There is a need for diagnostic and prognostic biosignatures to improve long-term outcomes in inflammatory bowel disease (IBD). Here, we describe the establishment of the Swedish Inception ...

Background Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis, ...

IBD: Conversely, treatment for IBD aims to decrease inflammation and manage the immune system. Treatment may include anti-inflammatory medication (e.g., aminosalicylates), corticosteroids ...

Key Takeaways. Allogeneic HSCT achieved 92% sustained, medication-free remission and 100% survival in children with monogenic IBD, highlighting its potential as a transformative treatment.

IBD/TIPP Economic Optimism 51.7 vs. 53.2 forecast By Investing.com - Apr 04, 2017 Investing.com - The IBD/TIPP economic optimism index rose less-than-expected last month, official data showed on ...

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the field of ...

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed ...

A systematic search of published reports was carried out in three electronic databases from 1966 on to identify relevant articles relating to tennis injuries. There were 39 case reports, 49 laboratory ...

FFTY – Innovator IBD® 50 ETF – Check FFTY price, review total assets, see historical growth, and review the analyst rating from Morningstar.